Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer

Akira Inoue, Frederick S. Robinson, Rosalba Minelli, Hideo Tomihara, Bahar Salimian Rizi, Johnathon L. Rose, Takahiro Kodama, Sanjana Srinivasan, Angela L. Harris, Andy M. Zuniga, Robert A. Mullinax, Xiaoyan Ma, Sahil Seth, Joseph R. Daniele, Michael D. Peoples, Sara Loponte, Kadir C. Akdemir, Tin Oo Khor, Ningping Feng, Jason RoszikMary M. Sobieski, David Brunell, Clifford Stephan, Virginia Giuliani, Angela K. Deem, Takashi Shingu, Yonathan Lissanu Deribe, David G. Menter, Timothy P. Heffernan, Andrea Viale, Christopher A. Bristow, Scott Kopetz, Giulio F. Draetta, Giannicola Genovese, Alessandro Carugo

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences